COLVIN: Get ready for a perfect storm in Worker’s Compensation
Rates are set to rise as insurers increasingly note the link between older workers’ health and productivity.
Health Care & Insurance
Articles
BURTON: Accountability care organizations need good data
Concept is likely ahead of technical ability to make it work.
Patient referrals can be lucrative for hospitals
Physician liaisons are becoming key in recruiting efforts.
Hospitals push preemptive care with special programs
Hospitals around Indianapolis and the nation are expanding programs to help people before they become patients. They are trying to teach cooking as well as treat cancer, to do social work as well as do surgery.
Endocyte pulls trigger on European drug submission
Endocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter of this year after the European Commission granted it orphan drug status.
Do electronic records really save money?
Even though researchers at the Indianapolis-based Regenstrief Institute Inc. demonstrated more than 20 years ago that electronic health records and test ordering systems significantly reduced costs in Indianapolis’ Wishard Health Services’ system, a recent study of electronic health records among office-based physicians came to the opposite conclusion.
Angel investors love health care deals
Health care venture capital has become scarcer in Indiana the past two years, but there are indications that angel investors are picking up some of the slack.
FTC asks critics of Express Scripts-Medco deal for ideas
Two pharmacy groups opposing Express Scripts Inc.’s proposed acquisition of Medco Health Solutions Inc. said they were asked by the U.S. Federal Trade Commission to suggest ways to revise the $29.1 billion deal so it wouldn’t harm competition.
Hospitals to build $14M medical center in Bargersville
Community Health Network and Johnson Memorial Hospital plan to spend $14 million to build a medical office building and outpatient center in Bargersville. The 70,000-square-foot facility is scheduled to be completed in mid-2013.
Lilly to try again to remove poison-pill provisions
Eli Lilly and Co.’s board is once again recommending the removal of a provision that makes the company an almost impossible target for hostile takeovers. The same proposal has fallen slightly short at each of the past two annual shareholder meetings.
Tornadoes may cost insurers $2B, risk modeler says
Tornadoes that slammed five states in the U.S. Midwest and South last week may generate as much as $2 billion in claims costs for insurers, risk-modeling firm Eqecat Inc. says.
Arcadia: Don’t buy our stock
Arcadia Resources Inc. is telling shareholders not to buy its stock because it is out of cash and faces a $40 million pile of debt that comes due on April 1.
WellPoint replaces fired Medicare plan chief
Venkata Rajamannar Madabhushi will take control of the various Medicare Advantage plans WellPoint runs around the country, replacing Brian Sassi, whom WellPoint fired last month.
FDA removes hurdle in Endocyte’s path to drug approval
Endocyte Inc. can start enrolling patients again in a clinical trial of its experimental cancer drug, the company announced Monday, clearing away a hurdle to getting the drug approved in Europe.
Home Health Depot plans to add up to 80 jobs
The medical equipment company said it will invest $1.4 million to expand its headquarters on the north side of Indianapolis and its customer-fulfillment operations across the state.
AIT Labs exec succeeding founder Evans as CEO
The promotions of several executives follow the Indianapolis-based clinical testing company’s announcement in January that it was cutting jobs and restructuring its business.
Anthem seeking state rule change allowing doctors to practice online
Anthem Blue Cross and Blue Shield has renewed its push to bring online care to the Indiana market, including video. It has asked the state’s Medical Licensing Board to relax a 2003 rule that stands in its way.
Lilly settles Zyprexa marketing suit for $1.4 billion
Indianapolis-based Lilly pleaded guilty to one violation of the Food, Drug and Cosmetic Act on Thursday and agreed to pay $1.42 billion to settle both that criminal charge as well as civil lawsuits in which it did not admit wrongdoing.
New drugmaker code deprives docs of football, lunch for 2
Doctors can still get free samples of medicines, but not football tickets or lunch for their spouses, under a revised code of conduct drafted by a global drug industry trade group that counts Eli Lilly as a member.